Enliven Therapeutics

Enliven Therapeutics is one of the...

• Russell 3000.

Enliven Therapeutics is a company listed under the stock ticker ELVN (US).

Acquisition, funding and merger involving Enliven Therapeutics.

• Imara and Enliven Therapeutics have announced they will merge  (posted on October 21 2022)..

View the org chart displaying its 13 main executives

Most searched biographies at Enliven Therapeutics

• Sam Kintz, Chief Executive Officer and Director
• Rich Heyman, Director
• Rahul Ballal, Director

Popular executive movements at Enliven Therapeutics

• Lori Kunkel has joined the company as Director  (posted on April 12 2024).

Create your alert
to follow the executive moves at Enliven Therapeutics.

Enliven Therapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Enliven Therapeutics

• Press Release | Enliven Therapeutics
• Press Release | Enliven Therapeutics
• Press Release | Enliven Therapeutics

Social media about Enliven Therapeutics

• Enliven Therapeutics on Wikipedia, Google News & Yahoo Finance
• Enliven Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Sam Kintz

Call Enliven Therapeutics at +1 720...

View the org chart

Register to receive your alert

Report an error